MetaVia Inc.
- MTVA
- NASDAQ
- Biotechnology
- Clinical-Stage Biotech (Cardiometabolic)
$1.23
Today −2.38%Quote Oct 19, 2026, 08:00 PM UTC
−28.90%over the last month
Max drawdown −28.9%From 1-month high −28.9%3 months −22.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About MetaVia
Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardiometabolic disorders.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
8
Market value
$8.1M
Quote Oct 19
Floor
$1.17
4.9% below price
Resistance
$1.37
11.4% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MTVAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free